Track and Trace system for export of Pharmaceuticals

Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments along with maintaining the Parent-Child relationship in the levels of packaging and their movement in supply chain- Extension of date of implementation – Public Notice No. 39/2023

In exercise of the powers conferred under Paragraph.2.04 of the Foreign Trade Policy 2023, as amended from time to time, the Director General of Foreign Trade hereby amends Pata 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated 05.12,2017 read with Public Notice No. 52/ 2015-20 dated 05.01.2016, Public Notice No. 05/2015-20 dated 09.05.2018, Public Notice No. 43/2015-2020 dated 01. I 1.2018, Public Notice No. I6/2015-2020 dated 04.07.2019, Public Notice No. 66/2015-2020 dated 30.03.2020, PubliC NotiGe No. 16/2015- 2020 dated 22.9.2020, Public Notice No. 46/2015-20 dated 30.03,2021, Public Notice No. 01/2015- 2020 dated 04.01.2022, Public Notice No. 3/2023 dated 03.04.2023 and Public Notice No. 26/2023 dated 04.08.202S on laying down in the procedure for implementation of the Track and Trace system for export consignments of drug formulations.

In Para 2.76 (vi) and (vii) of Handbook of Procedure – 2023 (as amended erstwhile Para 2.90 A of HBP 2015-2020), the date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to 01.02.2025 for both SSI and non SSI manufactured drugs”.

Effect of this Public Notice:
The date for implementation of Trach arid Trace Bystem for export of drug formulations ‘its respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to 01.02.2025 for both SSI and non SSI manufactured drugs.

Go to DGFT

Read More on DGFT